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Cerebral perfusion may be altered in sepsis patients. However, there are conflicting
findings on cerebral autoregulation (CA) in healthy participants undergoing the
experimental endotoxemia protocol, a proxy for systemic inflammation in sepsis. In the
current study, a newly developed near-infrared spectroscopy (NIRS)-based CA index
is investigated in an endotoxemia study population, together with an index of focal
cerebral oxygenation.
Methods: Continuous-wave NIRS data were obtained from 11 healthy participants
receiving a continuous infusion of bacterial endotoxin for 3 h (ClinicalTrials.gov
NCT02922673) under extensive physiological monitoring. Oxygenated–deoxygenated
hemoglobin phase differences in the (very)low frequency (VLF/LF) bands and the Tissue
Saturation Index (TSI) were calculated at baseline, during systemic inflammation, and at
the end of the experiment 7 h after the initiation of endotoxin administration.
Results: The median (inter-quartile range) LF phase difference was 16.2◦ (3.0–52.6◦)
at baseline and decreased to 3.9◦ (2.0–8.8◦) at systemic inflammation (p = 0.03). The
LF phase difference increased from systemic inflammation to 27.6◦ (12.7–67.5◦) at the
end of the experiment (p = 0.005). No significant changes in VLF phase difference were
observed. The TSI (mean ± SD) increased from 63.7 ± 3.4% at baseline to 66.5 ± 2.8%
during systemic inflammation (p= 0.03) and remained higher at the end of the experiment
(67.1 ± 4.2%, p = 0.04). Further analysis did not reveal a major influence of changes in
several covariates such as blood pressure, heart rate, PaCO2, and temperature, although
some degree of interaction could not be excluded.
Discussion: A reversible decrease in NIRS-derived cerebral autoregulation phase
difference was seen after endotoxin infusion, with a small, sustained increase in TSI.
These findings suggest that endotoxin administration in healthy participants reversibly
impairs CA, accompanied by sustained microvascular vasodilation.
Keywords: near-infrared spectroscopy, human endotoxemia model, dynamic cerebral autoregulation, sepsis,
cerebral perfusion
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INTRODUCTION
Sepsis is defined as life-threatening organ dysfunction caused by a
dysregulated host response to infection (1). Apart from systemic
effects, sepsis patients may experience cerebral complications.
Sepsis-associated encephalopathy (SAE) is a severe complication
in sepsis (2) and is associated with increased mortality and
long-term cognitive impairment. The pathophysiology of SAE
is multifactorial, and inflammatory cytokines, alterations in
cerebral metabolism, and blood–brain-barrier compromise have
been described as etiological factors for the development of
SAE (2). In addition, there is increasing evidence for alteration
of the cerebral (micro-)circulation and cerebral autoregulation
(CA) during sepsis, which may play an important role in SAE
pathogenesis (3, 4).
The experimental human endotoxemia model is a
standardized reproducible model in which healthy volunteers are
challenged with endotoxin (lipopolysaccharide, LPS) to induce a
systemic inflammatory response. This model can be used to study
systemic inflammation and has been used to investigate several
phenomena associated with sepsis, including cerebral perfusion,
cerebral (micro-) vascular function, and SAE (5–9). In general,
although alterations in CA are seen in patients with SAE, there
are conflicting findings regarding CA in healthy participants
undergoing experimental endotoxemia. Three studies have
estimated the dynamic cerebral autoregulation (DCA) with
transfer function analysis (TFA), in which the temporal relation
was determined between oscillations in arterial blood pressure
(ABP) and cerebral blood flow velocity (CBFv) measured with
transcranial Doppler (TCD). DCA is quantified with “gain” and
“phase difference”. Two earlier studies reported an improvement
in DCA (reduced gain and increased phase difference) upon
infusion of 2 ng/kg bacterial LPS (7, 10). In a recent study, Van
den Brule et al. investigated DCA in an endotoxemia study with
a continuous infusion of, in total, 4 ng/kg bacterial LPS. No
changes in gain or phase difference were found (5).
CA has also been assessed with measurements of ABP and
near-infrared spectroscopy (NIRS), a non-invasive technique
that uses near-infrared light to calculate the concentration of
hemoglobin (Hb) in the cerebral cortex (11, 12). Recently, a
newDCAmeasurementmodel that employs only high-frequency
continuous-wave NIRS measurements on the frontotemporal
scalp was developed (13). In short, the temporal relation between
the concentration of oxygenated (OxyHb) and deoxygenated
hemoglobin (HHb) is determined with TFA, which results in
phase difference values analogous to TFA for ABP and CBFv.
Correction for transit time and blood flow/blood volume (TT-
BF/BV) oscillations for phase difference values is needed, after
which NIRS-derived DCA phase difference values were similar
to the phase difference values obtained via the classic TCD-
and ABP-based method in healthy volunteers during rest and
hypercapnia (13).
The NIRS technique to assess DCA has several advantages
over the technique using TCD and ABP: it requires little
operator experience, is more comfortable for the participant,
and allows for long-term measurements. These advantages could
provide a higher signal-to-noise ratio for the NIRS compared
to the TCD/ABP method. Further studies in clinically relevant
populations are therefore warranted. In the current study,
unilateral, frontotemporal NIRS measurements obtained from
the same healthy participants that were studied by Van den
Brule et al. during experimental endotoxemia (5) were analyzed
to explore the temporal dynamics of NIRS-derived CA. We
hypothesized that possible changes in CA can be detected
more easily with NIRS than with TCD and ABP due to the
aforementioned advantages of the NIRS-CA technique.
We compared the temporal dynamics of NIRS-derived
dynamic cerebral autoregulation as characterized by TFA phase
difference before, during, and after administration of endotoxin.
Furthermore, we investigated the dynamics of the Tissue
Saturation Index (TSI), a more common and clinically used
NIRS measure of cerebral oxygenation, as the TSI is thought to
be susceptible to changes in cerebral blood volume (CBV) or
cerebral blood flow (CBF).
Lastly, the relation was explored between phase difference
and TSI, and several potential confounders that have been
described to influence cerebral perfusion and DCA: mean
arterial pressure (MAP), PaCO2, pH, temperature, heart rate,
inflammatory cytokine concentrations, and power in ABP and
NIRS oscillations (14, 15).
MATERIALS AND METHODS
Participants and Study Protocol
NIRS data from 11 participants were used from an existing
dataset of healthy adult males undergoing an experimental
human endotoxemia study [ClinicalTrials.gov NCT02922673
(16)]. Of the original 13 datasets, two participants were excluded
because of the insufficient quality of NIRS data resulting from
excessive movement artifacts.
A comprehensive study protocol for the study has been
published previously (5, 16). A summary of the study protocol
is provided here. A continuous infusion of bacterial LPS was
employed under extensive vital sign monitoring, with additional
NIRS measurements. A schematic description of the protocol
is provided in Figure 1. Data on age, body mass index (BMI),
resting heart rate, MAP, and (tympanic) body temperature
were obtained at baseline (T = −60min). All participants
received pre-hydration with 1.5 L of 2.5% glucose/0.45% saline
solution in the hour before LPS administration, followed by
150-ml/h continuous hydration until the end of the experiment
(5). Purified LPS (lipopolysaccharide, E. coli Type O113, lot
no. 94332B4; List Biological Laboratories, Campbell, USA) was
dissolved in normal saline (0.9%). An intravenous loading
bolus of 1 ng/kg body weight was administered, followed by a
continuous infusion of 1 ng/kg body weight/hour for a period of
3 h (5).
Monitoring and Data Collection
Monitoring of clinical parameters included continuous invasive
ABP, electrocardiography, arterial oxygen saturation (SpO2),
intermittent tympanic temperature, TCD-derived cerebral blood
flow velocity in the middle cerebral artery (MCA), arterial blood
gas, and inflammatory cytokine concentrations (5, 16).
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FIGURE 1 | Setup of the human endotoxemia trial. The numbers indicate the measurements at (1) baseline, (2) systemic inflammation, and (3) the end of the
experiment. ABG, arterial blood gas; HD, hemodynamic; LPS, lipopolysaccharide; NIRS, near-infrared spectroscopy; TCD, transcranial Doppler. Figure reproduced
with permission from Figure 1 in Van den Brule et al., Shock (2018), doi: 10.1097/SHK.0000000000001003.
NIRS recordings were performed at four time points:
60min before LPS administration (baseline), during systemic
inflammation at 150 and 300min after the initiation of LPS
administration, and at the end of the experiment, 420min after
the initiation of LPS administration. A continuous-wave NIRS
device (Portalite, ArtinisMedical Systems, Elst, The Netherlands)
was placed on the frontotemporal forehead. Near-infrared light
was transmitted with wavelengths of 760 and 850 nm by a light-
emitting diode and was received by a photodiode at 35-mm
inter-optode distance. Data were obtained at 50-Hz sampling
frequency with device-specific acquisition software (Oxysoft,
Artinis Medical Systems, Elst, The Netherlands). Changes in
OxyHb and HHb were derived using the modified Beer–Lambert
Law (17).
All OxyHb and HHb data were systematically inspected
for artifacts and noise with in-house developed Labview data
visualization and correction software (Labview 2015, National
Instruments, Austin, TX, United States), which has been used
before by our group (13). The artifacts were visually identified
and removed by linear interpolation as recommended by
the international Cerebral Autoregulation Research Network
(CARNet) (18). For longer artifacts (>5 s), artifact containing
data were removed. A second reviewer visually inspected the
resulting data for any remaining artifacts. At least 5min of
high-quality data were required for each time point as is
recommended (18).
The mean cerebral TSI was calculated from the artifact-
corrected OxyHb and HHb data using spatially resolved




The relationship between OxyHb and HHb was determined with
TFA following CARNet recommendations (18). Power spectral
density and cross-spectral density estimates were determined
using Welch’s method (100-s epochs, 50% window overlap).
Coherence, gain, and phase difference were computed and
trichotomized into one of three frequency bands: very low
frequency (VLF): 0.02–0.07Hz, low frequency (LF): 0.07–0.2Hz,
and high frequency (HF): 0.2–0.5Hz. Gain and phase difference
values were excluded if the corresponding coherence values were
below the window-dependent coherence threshold as defined in
the CARNet White Paper (18).
The capillary TT-BF/BV correction method developed by
our group was applied to the phase difference values after TFA
calculation (13). In short, a linear trend line was fitted to the HF
band phase difference values. Only data sections that yielded at
least five consecutive frequency bins with significant coherence
were used for line fitting, thereby avoiding inclusion of bins
with significant coherence that arose by chance. Subsequently,
this trend line was subtracted from the LF/VLF phase difference
values, thereby obtaining the NIRS-derived TT-BF/BV-corrected
CA estimation. NIRS-derived CA estimates were defined as TT-
BF/BV-corrected VLF and LF phase differences. These were
calculated for each time point for whichNIRS data were available.
Data Pooling
For themeasurements at 150min after the initiation of endotoxin
administration, movement-related artifacts were prominent in
some of the NIRS data (healthy volunteers getting sicker), so
for this time point, data from only n = 7 participants were
available. Although there was a difference in inflammatory
response as measured by plasma cytokine concentration between
150 and 300min after the initiation of endotoxin administration,
inflammation at both time points was markedly higher than
at baseline or at the end of the experiment as was reported
previously (5). We therefore decided to pool the data at these
two time points by averaging to obtain one “intra-inflammatory”
measurement for each participant. If measurements were only
available at either 150 or 300min, these data were used. For
further analysis, data were therefore obtained from three time
points: (1) baseline (−60min), (2) systemic inflammation, and
(3) at the end of the experiment (420 min).
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MAP (mmHg) Mean ± SD 86.1 ± 10.7 76.6 ± 6.6 73.3 ± 6.5 0.0103 0.0032 0.2168
Heart rate (/min) Mean ± SD 61.5 ± 6.9 88.7 ± 13.5 84.1 ± 10.7 0.0000 0.000 0.0427
Temperature (◦C) Median (IQR) 36.8 (36–36.8) 38.3 (37.9–38.6) 37.8 (37.5–38.1) 0.0010 0.0010 0.0186
SpO2 (%) Median (IQR) 100 (100) 98.5 (98.0–99.5) 99 (98 - 100) 0.0020 0.0547 0.2891
pH Median (IQR) 7.38 (7.37–7.39) 7.43 (7.42–7.45) 7.42 (7.41–7.45) 0.0010 0.0020 0.6563
PaO2 (kPa) Mean ± SD 14.0 ± 1.2 12.5 ± 1.7 13.7 ± 1.0 N.S. N.S. N.S.
PaCO2 (kPa) Median (IQR) 5.41 (4.73–5.69) 4.85 (4.36–5.09) 4.79 (4.65–5.47) 0.0020 0.042 0.4131
IL-6 (ng/ml) Median (IQR) 9.9 (3.2–30.4) 395 (134–1467) 17.2 (10.3–24.2) 0.0010 0.4131 0.0010
TNFα (pg/ml) Median (IQR) 11.7 (7.3–17.7) 243 (131–476) 43.8 (31.6–54.4) 0.0010 0.0029 0.0010
IL, interleukin; IQR, inter-quartile range; MAP, mean arterial pressure; N.S., repeated-measures test statistic not significant; PaO2/PaCO2, arterial partial pressure of oxygen/carbon
dioxide; p-value, post-hoc test p-value for difference between time points; SpO2, arterial saturation of oxygen; SD, population standard deviation; TNFα, tumor necrosis factor alpha;
TP, time point.
Statistical Analysis
Data distribution was assessed for normality using histograms
and the Shapiro–WilkW-test and for sphericity using Mauchly’s
test. For normally distributed data, the between-time point
differences were determined using a repeated-measures analysis
of variance (rm-ANOVA). For non-normally distributed data,
the non-parametric Friedman test was used. Paired t-tests and
Wilcoxon signed rank tests were used for post-hoc testing in
case of normally and non-normally distributed data, respectively.
The significance level was set at α = 0.05. Pearson’s correlation
coefficient with Benjamini–Hochberg correction was used to
explore the relation between the change in phase difference and
TSI between different time points and changes in hemodynamic
confounders related to cerebral perfusion and CA. Statistical
analyses were performed using Stata/SE 16 (StataCorp., College





The participants were healthy young adults (22.4± 1.6 years old)
with a BMI of 24.2± 2.4 kg/m2 and normal baseline physiological
measurements as can be seen in Table 1. The hemodynamic
parameters at each time point are provided in Table 1 and
Figure 2. A sustained decrease in MAP and a reversible decrease
in PaCO2 was observed, respectively. Heart rate, temperature,
and pH showed a reversible increase.
NIRS-Derived Cerebral Autoregulation
The NIRS measurement duration was 20.9 ± 7.4min (mean
± SD). After the application of TT-BF/BV correction, phase
difference values were obtained in the VLF and LF bands (data
on coherence, gain, and phase difference for all frequency bands
can be found in the Supplementary Material). Phase difference
values are provided for each participant at each time point
for both the VLF and LF frequency bands in Figures 3A,B,
respectively. No statistically significant differences in VLF phase
difference values were found between the different time points
(χ2 = 5.10, p = 0.08, Friedman test), although a trend toward
lower values at time point 2 could be observed. For the LF band,
a statistically significant difference in phase difference values
between the time points was found (χ2 = 7.82, p= 0.02). Median
(IQR) LF phase difference values decreased from time point 1
(16.2◦, 3.0–52.6◦) to time point 2 (3.9◦, 2.0–8.8◦; Z = 2.13, p =
0.03). The LF phase difference values were also higher at time
point 3 (27.6◦, 12.7–67.5◦) than at time point 2 (Z = −2.67, p =
0.005, all Wilcoxon signed rank tests). No significant difference
between time points 1 and 3 was found (Z =−1.78, p= 0.08).
No correlation was found between changes in LF phase
difference between the time points and changes in the following
variables: LF band power spectral density (PSD) in OxyHb, HHb,
or ABP or PaCO2, pH, and IL-6 or TNFα concentrations (allR
2
<
0.25, p> 0.1; see Supplementary Material for details). A positive
correlation was found between changes in LF phase difference
between time points 1 and 2 and changes in MAP (R2 = 0.50,
p = 0.015). A negative correlation was found between changes
in LF phase difference between time points 2 and 3 and changes
in heart rate (R2 = 0.45, p = 0.024) and temperature (R2 =
0.65, p= 0.003). Only the latter correlation remained statistically
significant after correcting for multiple comparisons.
Tissue Saturation Index
TSI values are provided for each participant at each time point
in Figure 3C. There was a significant difference in TSI between
time points (F = 4.78, p = 0.02, rm-ANOVA). Post-hoc testing
indicated that the TSI was higher at time points 2 (66.5 ± 2.8%)
and 3 (67.1 ± 4.2%) than at time point 1 (63.7 ± 3.4%) [t(10) =
−2.46, p = 0.03 and t(10) = −2.40, p = 0.04, respectively]. No
significant differences between time points 2 and 3 were found
[t(10) =−0.68, p= 0.51].
No correlation was found between changes in TSI between
the time points and changes in the following variables: LF band
PSD in OxyHb, HHb, or ABP, PaCO2, temperature, heart rate,
and IL-6 or TNFα concentrations (all R2 < 0.25, p > 0.1)
(Supplementary Material). A weak, negative correlation was
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FIGURE 2 | Boxplots of hemodynamic and clinical parameters of the participants (n = 11) for each time point with results of the statistical comparisons. (A) Mean
arterial pressure (rm-ANOVA), (B) heart rate (rm-ANOVA), (C) temperature (Sign. Rnk), (D) PaCO2 (Sign. Rnk), (E) PaO2 (Sign. Rnk), (F) pH (Sign. Rnk), (G) SpO2
(Sign. Rnk), (H) IL-6 (Sign. Rnk), and (I) TNFα (Sign. Rnk). IL, interleukin; MAP, mean arterial pressure; PaO2/PaCO2, arterial partial pressure of oxygen/carbon dioxide;
rm-ANOVA, repeated-measures analysis of variance; Sign. Rnk, Wilcoxon’s signed rank test; SpO2, arterial saturation of oxygen; TNFα, tumor necrosis factor alpha.
*p < 0.05 for difference between time points.
FIGURE 3 | TT-BF/BV-corrected phase differences (degrees) between OxyHb and HHb for the (A) very low frequency and (B) low frequency bands and (C) mean
tissue saturation index (%) calculated with spatially resolved spectroscopy at three time points: (1) baseline, (2) systemic inflammation, and (3) at the end of the
experiment. The per time point group median is shown by the black line.
found between changes in TSI between time points 1 and 2 and
pH (R2 = 0.40, p= 0.04).
DISCUSSION
Interpretation of the Results
In this study, NIRS-derived DCA estimations were obtained
during experimental human endotoxemia with a continuous
infusion of bacterial LPS. The TT-BF/BV-corrected phase
difference values in the LF band were significantly lower during
systemic inflammation compared with baseline and at the end
of the experiment. In addition, the TSI increased significantly
during systemic inflammation compared with baseline and
remained significantly higher at the end of the experiment.
We found a reversible decrease in LF phase difference
measured with NIRS, which suggests impaired CA during
endotoxemia in healthy volunteers. The extensive physiological
changes resulting from endotoxin administration could
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theoretically underlie the observed NIRS changes, but after
extensive analysis, we found no unambiguous explanation
for the observed decrease in LF phase difference measured
with NIRS.
A decrease in LF phase difference between time points
1 (baseline) and 2 (systemic inflammation) correlated with
a decrease in MAP, although this was not significant after
correcting for multiple comparisons. Furthermore, although
the LF phase difference increased between time points 2 and
3 (end of the experiment), MAP did not, attenuating the
interpretation of a major influence of MAP changes on LF
phase. Furthermore, an increase in LF phase correlated with a
decrease in heart rate and temperature, although only the latter
remained statistically significant after correcting for multiple
comparisons and only between time points 2 and 3. There
was no correlation with temperature and heart rate changes
between time points 1 and 2, supporting the interpretation
that these changes may not be an important confounder.
Other potential confounders that we analyzed were changes
in inflammatory cytokines (IL-6 and TNFα) and PaCO2. All
these variables did not correlate with the changes in LF phase.
Note that the absence of correlations with potential confounders
in our small sample should not be interpreted as proof of
the absence of any such relationship: it could be that there
actually is a (weak) relationship that could be identified in
larger samples.
Previous data by Brassard and colleagues support the idea
that the improvement in dynamic CA that they found during
experimental endotoxemia correlated with a decrease in carbon
dioxide tension (7). The relation between hypocapnia and
DCA phase difference is well recognized (21, 22). In our
study, relative hypocapnia and alkalosis were also present,
which are expected to induce an increase in LF band DCA
phase difference. The opposite was observed (decrease in LF
band phase). It could be that the effect of hypocapnia is
masked in part by other physiological changes that occurred
in our endotoxemia population, among others the decrease
in MAP or a higher inflammatory response. Indeed the
population studied by Brassard et al. had no decrease
in MAP upon a lower bolus administration of 2 ng/kg
of endotoxin.
The small but sustained increase in TSI that was observed
may have resulted from microvascular vasodilatation, with
concomitant increases in CBV and/or CBF. We could not
further clarify this phenomenon based on our data, as we
found only a weak, non-significant relation between the increase
in TSI between time points 1 and 2 and an increase in
pH. However, both an increase in TSI and a decrease in
LF phase difference measured with NIRS are consistent with
the interpretation of cerebral microvascular vasodilatation in
response to endotoxin infusion.
No significant changes in VLF phase difference were found.
We hypothesize that this is due to the limited reproducibility
of VLF phase difference values using TFA (15, 23). A variation
in LF phase difference values was seen between the participants
showing an evident reversible decrease during endotoxin-
induced systemic inflammation and the participants with
consistently low phase difference values with limited variation.
We hypothesize that CAwas consistently “off” in the latter group,
given the known non-stationarity of CA function, also in healthy
participants (14).
Comparison With TCD- and ABP-Derived
DCA
The reversible decrease in NIRS-derived LF phase difference
observed in this study has not been found with TFA using
TCD and ABP measurements as reported previously (5). It
could be that the autoregulatory dysfunction observed upon
endotoxin administration mainly demonstrates itself in a patchy
distribution in the cortical microvasculature, the effects of which
cannot be easily found in TCD-based CBF velocity in the MCA.
Another possibility is that some of the CA effects of endotoxin
administration occur at the level of pre-capillary sphincters and
not only at the level of the cerebral arterioles themselves (13,
24, 25). The NIRS measurements could be sensitive to both
microvascular regulators. The OxyHb and HHb components are
present proximal and distal to both regulators, making NIRS
suitable for the detection of alterations in the function of both
the arterioles and the pre-capillary sphincters. The TCD-derived
CBFv could be only sensitive to the upstream resistance effects
of the arterioles. Another explanation may be methodological.
The variation in TFA analysis has been shown to decrease
with measurement duration (23). In our study, the mean ±
SD duration of the NIRS measurements was 20.9 ± 7.4min,
compared with 5min as previously reported for TCD and
ABP (5).
Limitations
We recognize several limitations of our study. The sample size
of 11 participants prevents an extensive, multivariate analysis
of the data, and it may limit the external validity of the
results. Furthermore, we pooled the NIRS parameters from two
measurements (T = 150 and 300min) due to movement artifacts
in some measurements. This allowed an “intra-inflammatory”
measurement for each participant, and it limited the number
of statistical comparisons. We consider this justified and
advisable, as the concentration of pro-inflammatory cytokines
was high at both time points as published previously, indicating
the systemic inflammatory response (5). Longer (>30min)
measurements would allow for more artifact-free data, but this
was unfeasible in the current endotoxemia setup. The cerebral
origin of the NIRS-only DCA measurements has previously
been confirmed by comparison against TCD/ABP-derived DCA
during rest and hypercapnia. However, we cannot exclude the
confounding effects of changes in extracerebral perfusion that
may have resulted from systemic microvascular vasodilation in
the febrile phase of systemic inflammation in the current study.
It should be mentioned that one participant was in a consistent
hyperventilation (hypocapnic) state during the entire experiment
(3.15 < PaCO2 < 3.72 kPa) but was not excluded from the
analysis to prevent selection bias. Lastly, the NIRS measurements
are sensitive to movement artifacts, which was exemplified in our
study as we had to exclude measurements from two participants.
Movement-related artifacts may however be less pronounced
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in clinical target populations, including sedated patients in
the ICU.
Future Perspective
The NIRS-only technique is a non-invasive, easy-to-use modality
for the measurement and monitoring of CA. This study provides
first insights that NIRS-only-derived DCA changes during
experimental human endotoxemia. It provides indications for
an influence of bacterial endotoxin on DCA, which warrants
further investigation in larger endotoxemia studies. Moreover, it
could be interesting to investigate NIRS-derived DCA in a sepsis
population, as the systemic inflammatory response in sepsis is
higher, longer, and has a stronger hemodynamic effect than
during experimental endotoxemia, and there is more variability
in (cerebrovascular) outcome.
CONCLUSION
Our findings suggest that endotoxin administration in healthy
volunteers results in changes in cerebral microvascular
autoregulation and microvascular vasodilation.
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